Addition of Rituximab to Involved-Field Radiation Therapy Prolongs Progression-free Survival in Stage I-II Follicular Lymphoma: Results of a Multicenter StudyMarco Ruella, Liliana Devizzi, Guido Gini et al.|International Journal of Radiation Oncology*Biology*Physics|2015Cited by 48